ban
Events

Rodman & Renshaw Annual Global Investment Conference;
Tuesday, September 13, 2011; 4:30 p.m. Eastern Time.
To access this event please click the following link http://www.wsw.com/webcast/rrshq20/dmed
D. Medical Industries Ltd. (NASDAQ:DMED; TASE:DMED)("D. Medical" or the "Company”), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, today announced that Amir Loberman, the Company’s Chief Financial Officer, will present an update on the Company’s business at the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, September 13, 2011 at 4:30 p.m. Eastern Time.  The conference is being held at the The Waldorf-Astoria hotel in New York City, NY. Mr. Loberman’s presentation will be webcast live and archived for at least 30 days on the Company’s website under the "Webcasts" tab in the Investors section.


D. Medical to Release Fiscal 2011 Second Quarter Financial Results on August 31 - Conference Call to Follow.
D. Medical is pleased to invite all interested parties to participate in a conference call on August 31, 2011 at 8:30 a.m. (Eastern Time) 15:30 Israel Time during which the results will be discussed. Those wishing to access the live conference call by telephone should dial (877) 312-5445 (within the United States) or (253) 237-1128 (outside of the United States) several minutes prior to the beginning of the call. The call will also be webcast live and archived for 30 days on D. Medical's website at http://www.dmedicalindustries.com under the "Events" tab in the Investors section. Click here to access the webcast online registration




Efri Argaman, D. Medical's Chief Executive Officer, participated in the TASE-NASDAQ Biomed Conference on Monday, December 6. The conference was held in NASDAQ's Times Square headquarters in New York City and was launched with an opening bell ceremony featuring managers of 14 leading Israeli biomed companies, as well as the heads of NASDAQ and TASE. In addition to the opening bell ceremony, Mr. Argaman participated in the "Cutting Edge Device Panel" at 11:45 a.m. ET.


 

Click here to view event video



 
 
Powered by inmanage.com, Site design by Anna Design